Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma

Published:2017-06-22 Issue:1 Volume:36 Page:93-97
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Beltran Brady E.¹,Quiñones Pilar²,Morales Domingo²,Malaga Jose M.³,Chavez Julio C.⁴,Sotomayor Eduardo M.⁵,Castillo Jorge J.⁶^ORCID

Affiliation:

1. Department of Oncology and Radiotherapy; Hospital Nacional Edgardo Rebagliati Martins; Lima Peru

2. Department of Pathology; Hospital Nacional Edgardo Rebagliati Martins; Lima Peru

3. Department of Hematology; Hospital Alberto Seguin; Arequipa Peru

4. Division of Hematology and Oncology; Moffitt Cancer Center; Tampa, FL USA

5. Division of Hematology/Oncology; George Washington University Cancer Center; Washington DC USA

6. Division of Hematologic Malignancies, Dana-Farber Cancer Institute; Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2449/fullpdf

Reference29 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru;Beltran;Am J Hematol,2011

3. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations;Hoeller;Hum Pathol,2010

4. Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population;Hofscheier;Mod Pathol,2011

5. EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation;Montes-Moreno;Mod Pathol,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk‐stratification, and management;American Journal of Hematology;2024-07-03

2. Molecular Changes in Immunological Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells in Lymphoid Neoplasia;Biochemistry (Moscow);2024-05

3. Update: The molecular spectrum of virus-associated high-grade B-cell non-Hodgkin lymphomas;Blood Reviews;2024-05

4. Comparison of genomic alterations in Epstein–Barr virus‐positive and Epstein–Barr virus‐negative diffuse large B‐cell lymphoma;Cancer Medicine;2024-02

5. Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country;JCO Global Oncology;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3